SEC Filing Analysis: ARTIVION, INC. (AORT)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer sold shares valued at approximately $577k after exercising stock options, executed under a pre-arranged 10b5-1 trading plan.
• Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to influence the market.

Company Information

Field	Value
Company	ARTIVION, INC.
Ticker Symbol	AORT
CIK	0000784199
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Holloway Jean F
CIK	0001540065
Title/Position	SVP, General Counsel
Relationship	Officer

Transaction Details

This filing reports a series of 'exercise and sell' transactions over two days. The net result is a disposition of shares.

Field	Value
Form Type	4
Transaction Date	2025-11-14 & 2025-11-17
Transaction Code	M (Exercise), S (Sale)
Security Type	Common Stock
Shares Involved	12,787 (Sold)
Price Per Share	$45.00 - $45.17 (Sale Prices)
Total Value	$576,532 (Total Sale Value)
Shares Owned After	163,408
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$576,532
% of Market Cap	0.027%
Shares Transacted	12,787
% of Shares Outstanding	0.027%
Post-Transaction Ownership	163,408 shares (0.35% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $2.17 billion, a transaction of ~$577k is negligible and considered routine executive compensation liquidation.
• Ownership Concentration: The insider's post-transaction ownership of 0.35% is not a controlling stake, and the sale of 12,787 shares represents a minor reduction (~7.3%) of their total holdings.
• Dilution Impact: The exercise of options is the source of the shares sold. The number of shares is insignificant (0.027% of outstanding), posing no meaningful dilution risk to existing shareholders.
• Transaction Significance: The transaction's value and share count are far below the thresholds for moderate or high significance. The pre-scheduled nature further diminishes its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sales were executed under a Rule 10b5-1 plan, indicating they were pre-scheduled and not based on any new, non-public information. Such transactions are common for executive financial planning and tax purposes and typically do not impact stock price.

Volume & Sentiment

• Expected Volume Impact: Minimal. The number of shares sold is too small to significantly affect trading volume.
• Sentiment Indicator: Neutral. The market generally disregards pre-planned 10b5-1 sales from non-C-suite executives unless the size is exceptionally large.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly states in Footnote 1 that the option exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. This is the most critical piece of context, confirming the pre-planned nature of the trades.